Tissue Regenix Group (LON:TRX) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What Happened

Tissue Regenix Group plc (LON:TRX)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 61.32 ($0.77) and traded as low as GBX 58.03 ($0.73). Tissue Regenix Group shares last traded at GBX 58.03 ($0.73), with a volume of 26 shares changing hands.

Tissue Regenix Group Stock Down 2.3 %

The business has a fifty day moving average price of GBX 57.69 and a two-hundred day moving average price of GBX 61.22. The company has a current ratio of 3.74, a quick ratio of 2.36 and a debt-to-equity ratio of 35.69. The company has a market cap of £41.40 million, a price-to-earnings ratio of -5,812.50 and a beta of 1.61.

Tissue Regenix Group Company Profile

Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth.